HRB
H&R Block, Inc.
HRB has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
HRB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
HRB's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HRB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.3x | $50.73 | — |
| Cheap | 8.8x | $47.55 | -6.3% |
| Current | 9.4x | $50.73 | — |
| Fair | 13x | $69.30 | +37% |
| Expensive | 15x | $80.42 | +59% |
Historical ranges are pointers, not guarantees.
HRB's PE is in its cheap range at 9.4x. If earnings grow as analysts expect, today's price would be 8.3x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
HRB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HRB, with profitability improving.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HRB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.12 | +14% |
| Q3 2026 | $5.39 | +23% |
| Q2 2026 | $5.66 | +29% |
| Q1 2026 | $5.54 | +39% |
| Q4 2025 | $4.25 | +20% |
| Q3 2025 | $4.37 | +9.3% |
| Q2 2025 | $4.39 | +6.6% |
| Q1 2025 | $3.98 | -7.7% |
| Q4 2024 | $3.53 | -1.1% |
HRB has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
HRB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $224.3M | +10% |
| Q2 2026 | $1.1B | +3% |
| Q1 2026 | $2.4B | +5.3% |
| Q4 2025 | $198.9M | +11% |
| Q3 2025 | $203.6M | +5% |
| Q2 2025 | $1.1B | +4.6% |
| Q1 2025 | $2.3B | +4.2% |
| Q4 2024 | $179.1M | 0% |
HRB's revenue has grown year over year for seven quarters in a row: $224M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -103% | -1.7 points |
| Q2 2026 | 33% | -0.5 points |
| Q1 2026 | 43% | +0.3 points |
| Q4 2025 | -150% | +14 points |
| Q3 2025 | -102% | +16 points |
| Q2 2025 | 33% | +0.4 points |
| Q1 2025 | 43% | +0.5 points |
| Q4 2024 | -164% | -15 points |
HRB has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over HRB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
HRB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$379.2M | -$9.2M |
| Q2 2026 | $236.5M | -2% |
| Q1 2026 | $1.5B | +18% |
| Q4 2025 | -$649.5M | -$52.1M |
| Q3 2025 | -$370M | -$22.7M |
| Q2 2025 | $241.3M | -17% |
| Q1 2025 | $1.3B | -2.9% |
| Q4 2024 | -$597.4M | +$29.5M |
HRB has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
HRB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.5% | -5.8M shares |
| 1 year | -6.3% | -8.3M shares |
| 3 years | -16% | -23.2M shares |
| 5 years | -31% | -55M shares |
| Available history | -37% | -71M shares |
HRB has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
HRB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 2.2x | Moderate |
HRB's net debt is about 1.1 years of its operating earnings (EBITDA), down from 1.4 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HRB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.3 | Neutral |
| Stochastic | 63.0 | Neutral |
HRB's weekly RSI is 60 (neutral) and its Stochastic is 63 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HRB PE vs Consumer Cyclical Sector
| Metric | HRB | Sector median | Relative |
|---|---|---|---|
| PE | 9.4x | 18x | 48% below |
| PE % | 19 | 47 | 28 pts below |
HRB is trading at 9.4x earnings, a 48% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
HRB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.6 | 6.5% above |
| 20 week MA | $46.6 | 8.8% above |
| 50 week MA | $40.4 | 26% above |
| 100 week MA | $47.0 | 7.9% above |
| 200 week MA | $46.5 | 9.2% above |
HRB has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HRB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.4 | $15.5 | -34% |
| 2021 | $15.5 | $23.5 | +52% |
| 2022 | $23.5 | $39.2 | +66% |
| 2023 | $39.2 | $48.4 | +24% |
| 2024 | $48.4 | $53.4 | +10% |
| 2025 | $53.4 | $43.8 | -18% |
| 2026 YTD | $43.8 | $50.7 | +16% |
HRB has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.